Therapeutic effect of erythropoietin and its derivatives in the treatment of acute ischemic stroke
Stroke is the third leading cause of death and disability in industrialized countries. The estimated costs of stroke to the healthcare system are $85 billion in the United States and $40 billion in the European Union. Despite the extensive research over the past decades, only therapies aimed at rest...
Saved in:
| Main Authors: | Ramón Rama, Joan Ramon Torrella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-04-01
|
| Series: | Exploration of Neuroprotective Therapy |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1004101/1004101.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Edaravone's Safety Profile in Acute Ischemic Stroke
by: Laurence K. J. Batino, et al.
Published: (2024-12-01) -
NMDAR inhibitor preconditioned mesenchymal stromal cell-derived extracellular vesicles enhance post-stroke recovery by targeting excitotoxicity and neuronal regeneration
by: XiaoLu Zhang, et al.
Published: (2025-08-01) -
Neuroprotection, excitotoxicicity and nmda antagonists
by: RUBENS JOSÉ GAGLIARDI
Published: (2000-06-01) -
Neuroprotective therapy in acute ischemic stroke
by: A. A. Kulesh
Published: (2021-08-01) -
METABOLIC THERAPY IN PATIENTS WITH ISCHEMIC STROKE
by: L. B. Zavaliy, et al.
Published: (2018-04-01)